AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Bioceres Crop Solutions Corp.

$0.43 -$0.92 (-68.28%)
NASDAQ · 14 Sep 2026 20:00 UTC
Previous Close
$0.42
Day Range
$0.41$0.44
Year Range
$0.3$2.19
Market Cap
27.07M
AVG Volume
277.53K
Trailing/Forward PE
-0.11/8.56
PEG ratio
-0
Dividend Yield
-
Next Earnings Date
2026-11-12
Primary Exchange
NASDAQUS
Revenue (USD)
0200M400M600M20182019202020212022202320242025
BIOX Revenue (USD) by year
PeriodRevenue (USD)
2025325.47M
2024464.8M
2023419.45M
2022328.46M
2021206.7M
2020172.35M
2019160.31M
2018133.49M
Net Income (USD)
-60M-40M-20M020M20182019202020212022202320242025
BIOX Net Income (USD) by year
PeriodNet Income (USD)
2025-55.42M
20243.24M
202318.83M
2022-7.2M
2021-6.87M
20203.36M
2019-22.06M
2018-632.61K
Operating Income (USD)
020M40M60M20182019202020212022202320242025
BIOX Operating Income (USD) by year
PeriodOperating Income (USD)
202512.87M
202444.78M
202354.18M
202239.87M
202138.38M
202039.15M
20194.32M
20185.21M
EBITDA (USD)
-20M020M40M60M80M20182019202020212022202320242025
BIOX EBITDA (USD) by year
PeriodEBITDA (USD)
2025-8.38M
202458.5M
202363M
202244.96M
202136.33M
202032.73M
201912.67M
20188.64M
Cash Flows (USD)
-40M-20M020M40M20182019202020212022202320242025
BIOX Cash Flows (USD) by year
PeriodCash Flows (USD)
202535.3M
202418.93M
2023-19.97M
2022-26.51M
2021-20.13M
20201.11M
201927.79M
2018-6.45M
EPS (USD)
-1-0.500.520182019202020212022202320242025
BIOX EPS (USD) by year
PeriodEPS (USD)
2025-0.81
20240.04
20230.3
2022-0.17
2021-0.18
20200.08
2019-0.66
20180.06
Expenses (USD)
050M100M150M200MR&DSG&ACapex20182019202020212022202320242025
BIOX Expenses (USD) by year
PeriodExpenses (USD)
2025109.6M
2024151.17M
2023117.89M
202284.33M
202154.89M
202045.25M
201944.03M
201818.66M
Cash & Debt (USD)
0100M200M300MCashLong Term DebtShort Term Debt20182019202020212022202320242025
BIOX Cash & Debt (USD) by year
PeriodCash & Debt (USD)
202534.74M
202456.17M
202360.05M
202238.61M
202146.78M
202055.96M
20193.81M
2018886.18K
Debt ratios
00.511.5220212022202320242025
BIOX Debt ratios by year
PeriodDebt ratios
20251.53
20241.06
20231.11
20221.04
20211.41
Margins
0%20%40%60%20182019202020212022202320242025
BIOX Margins by year
PeriodMargins
202538.53%
202438.57%
202342.97%
202238.49%
202143.97%
202046.12%
201945.89%
201842.81%
Return on Capital
-40%-20%0%20%20182019202020212022202320242025
BIOX Return on Capital by year
PeriodReturn on Capital
2025-18.77%
20240.93%
20235.7%
2022-4.55%
2021-7.61%
20205.59%
2019-35.53%
2018-0.46%
Shares Outstanding
020M40M60M80M20182019202020212022202320242025
BIOX Shares Outstanding by year
PeriodShares Outstanding
202563.2M
202460.59M
202362.8M
202245.87M
202140.64M
202036.12M
201928.08M
20183.26M
Book Value Per Share (USD)
020406020182019202020212022202320242025
BIOX Book Value Per Share (USD) by year
PeriodBook Value Per Share (USD)
20254.67
20245.77
20235.26
20223.45
20212.22
20201.66
20192.21
201842.09
Total Assets (USD)
0250M500M750M1B20182019202020212022202320242025
BIOX Total Assets (USD) by year
PeriodTotal Assets (USD)
2025763.65M
2024850.63M
2023818.06M
2022518.22M
2021394.59M
2020297.56M
2019242.47M
2018117.79M
Employee Count
02505007501K2019202020212022202320242025
BIOX Employee Count by year
PeriodEmployee Count
2025751
2024983
2023790
2022565
2021497
2020447
2019409
PE Ratio
0100200300400med 148.58Sep 23Jan 24Apr 24Aug 24Nov 24Feb 25Jun 25
BIOX PE Ratio by year
PeriodPE Ratio
Jun 25183.34
Jun 25211.39
May 25204.27
May 25193.81
May 25194.64
May 25197.15
May 25192.13
Apr 25179.99
Apr 25173.29
Apr 25182.5
Apr 25172.88
Mar 25205.11
Mar 25182.5
Mar 25193.81
Mar 25217.25
Feb 25168.27
Feb 25195.11
Feb 25212.69
Feb 25237.99
Jan 25293.73
Jan 25307.88
Jan 25295.45
Jan 25280.44
Jan 25274.43
Dec 24272.29
Dec 24265.43
Dec 24285.58
Dec 24278.29
Nov 24305.31
Nov 24114.52
Nov 24115.26
Nov 24119.37
Nov 24121.24
Oct 24143.36
Oct 24154.62
Oct 24153.8
Oct 24159.13
Sep 24160.76
Sep 24168.75
Sep 24175.3
Sep 24206.84
Aug 24217.9
Aug 24203.77
Aug 24208.48
Aug 24204.79
Aug 24207.25
Jul 24226.3
Jul 24228.76
Jul 24229.78
Jul 24229.37
Jun 24229.57
Jun 24217.08
Jun 24220.97
Jun 24218.72
May 24241.25
May 2431.26
May 2432.86
May 2436.86
May 2434.66
Apr 2434.4
Apr 2434.6
Apr 2435.69
Apr 2436.12
Mar 2436.15
Mar 2435.98
Mar 2436.52
Mar 2437.8
Mar 2438.14
Feb 2459.9
Feb 2460.27
Feb 2462.05
Feb 2457.89
Jan 2462.42
Jan 2462.37
Jan 2463.33
Jan 2460.91
Dec 2362.78
Dec 2362.42
Dec 2361.82
Dec 2357.98
Dec 2356.52
Nov 2355.69
Nov 2353.68
Nov 2334.44
Nov 2335.66
Oct 2336.48
Oct 2335.34
Oct 2335.38
Oct 2334.98
Sep 2337.64
Sep 2337.11
Sep 2337.38
Sep 2337.54
Sep 2340.21
Aug 2344.6
Aug 2344.28
Aug 2347.6
Aug 2349.11
Jul 2350.27
Jul 2352.51
Free Cash Flow Yield
-100%0%100%200%300%400%med 25.49%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
BIOX Free Cash Flow Yield by year
PeriodFree Cash Flow Yield
Sep 26201.1%
Sep 26205.46%
Sep 26198.46%
Aug 26210.03%
Aug 26195.31%
Aug 26191.78%
Aug 26250.1%
Jul 26239.26%
Jul 26251.05%
Jul 26245.96%
Jul 26250.9%
Jul 26260.15%
Jun 26257.35%
Jun 26230.92%
Jun 26205.02%
Jun 26204.93%
May 26193.12%
May 26208.05%
May 26200.72%
May 26241.88%
May 26242.97%
Apr 26210.15%
Apr 26191.37%
Apr 26206.41%
Apr 26210.5%
Mar 26290.88%
Mar 26305.73%
Mar 26215.57%
Mar 26136.22%
Feb 26130.31%
Feb 26122.85%
Feb 26124.43%
Feb 26129.14%
Jan 2687.1%
Jan 2660.81%
Jan 2656.57%
Jan 2657.92%
Jan 2654.06%
Dec 2555.28%
Dec 2552.13%
Dec 2546.48%
Dec 2548.65%
Nov 2542.43%
Nov 2537.48%
Nov 2533.24%
Nov 2524.83%
Oct 2521.9%
Oct 2524.16%
Oct 2526.15%
Oct 2531.08%
Oct 2533.17%
Sep 2529.63%
Sep 2526.62%
Sep 2521.79%
Sep 2516.4%
Aug 2515.93%
Aug 2515.17%
Aug 2515.07%
Aug 2514.34%
Aug 2512.81%
Jul 2511.85%
Jul 2512.31%
Jul 2510.51%
Jul 259%
Jun 259.9%
Jun 259.79%
Jun 25-4.68%
Jun 25-4.06%
May 25-4.2%
May 25-4.43%
May 25-4.41%
May 25-4.36%
May 25-4.47%
Apr 25-4.77%
Apr 25-4.96%
Apr 25-4.71%
Apr 25-4.97%
Mar 25-4.19%
Mar 25-4.71%
Mar 25-4.43%
Mar 25-3.95%
Feb 25-5.1%
Feb 254.27%
Feb 253.92%
Feb 253.5%
Jan 252.84%
Jan 252.71%
Jan 252.82%
Jan 252.97%
Jan 253.04%
Dec 243.06%
Dec 243.14%
Dec 242.92%
Dec 242.99%
Nov 242.73%
Nov 245.1%
Nov 245.06%
Nov 244.89%
Nov 244.82%
Oct 24-3.03%
Price to Sales
00.250.50.7511.25med 0.32Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
BIOX Price to Sales by year
PeriodPrice to Sales
Sep 260.1
Sep 260.1
Sep 260.1
Aug 260.1
Aug 260.11
Aug 260.11
Aug 260.08
Jul 260.09
Jul 260.08
Jul 260.08
Jul 260.08
Jul 260.08
Jun 260.08
Jun 260.09
Jun 260.1
Jun 260.1
May 260.11
May 260.1
May 260.1
May 260.1
May 260.1
Apr 260.12
Apr 260.13
Apr 260.12
Apr 260.12
Mar 260.09
Mar 260.08
Mar 260.12
Mar 260.11
Feb 260.11
Feb 260.12
Feb 260.12
Feb 260.12
Jan 260.17
Jan 260.25
Jan 260.26
Jan 260.26
Jan 260.28
Dec 250.27
Dec 250.29
Dec 250.32
Dec 250.31
Nov 250.35
Nov 250.29
Nov 250.33
Nov 250.3
Oct 250.34
Oct 250.31
Oct 250.28
Oct 250.24
Oct 250.22
Sep 250.25
Sep 250.28
Sep 250.34
Sep 250.45
Aug 250.47
Aug 250.49
Aug 250.49
Aug 250.52
Aug 250.58
Jul 250.63
Jul 250.6
Jul 250.71
Jul 250.83
Jun 250.75
Jun 250.76
Jun 250.69
Jun 250.79
May 250.77
May 250.73
May 250.73
May 250.74
May 250.72
Apr 250.68
Apr 250.65
Apr 250.69
Apr 250.65
Mar 250.77
Mar 250.69
Mar 250.73
Mar 250.82
Feb 250.63
Feb 250.65
Feb 250.71
Feb 250.79
Jan 250.98
Jan 251.02
Jan 250.98
Jan 250.93
Jan 250.91
Dec 240.9
Dec 240.88
Dec 240.95
Dec 240.92
Nov 241.01
Nov 240.8
Nov 240.8
Nov 240.83
Nov 240.85
Oct 240.99
EV/EBITDA
510152025med 12.82Feb 24May 24Sep 24Dec 24Apr 25Jul 25Nov 25
BIOX EV/EBITDA by year
PeriodEV/EBITDA
Nov 2510.31
Oct 2510.76
Oct 2510.41
Oct 2510.15
Oct 259.64
Oct 259.47
Sep 259.77
Sep 2510.09
Sep 2510.78
Sep 2512.04
Aug 2512.19
Aug 2512.45
Aug 2512.48
Aug 2512.76
Aug 2513.46
Jul 2513.98
Jul 2513.72
Jul 2514.88
Jul 2516.21
Jun 2515.36
Jun 2515.46
Jun 2511.26
Jun 2512.15
May 2511.93
May 2511.59
May 2511.62
May 2511.7
May 2511.54
Apr 2511.15
Apr 2510.94
Apr 2511.23
Apr 2510.93
Mar 2511.95
Mar 2511.23
Mar 2511.59
Mar 2512.34
Feb 2510.78
Feb 259.74
Feb 2510.23
Feb 2510.93
Jan 2512.48
Jan 2512.88
Jan 2512.53
Jan 2512.11
Jan 2511.95
Dec 2411.89
Dec 2411.7
Dec 2412.26
Dec 2412.05
Nov 2412.8
Nov 2410.02
Nov 2410.06
Nov 2410.29
Nov 2410.39
Oct 2411.97
Oct 2412.6
Oct 2412.55
Oct 2412.85
Sep 2412.94
Sep 2413.38
Sep 2413.74
Sep 2415.49
Aug 2416.11
Aug 2415.32
Aug 2415.58
Aug 2415.38
Aug 2415.51
Jul 2416.57
Jul 2416.71
Jul 2416.76
Jul 2416.74
Jun 2416.75
Jun 2416.06
Jun 2416.28
Jun 2416.15
May 2417.4
May 2412.68
May 2413.18
May 2414.45
May 2413.75
Apr 2413.67
Apr 2413.73
Apr 2414.08
Apr 2414.21
Mar 2414.22
Mar 2414.17
Mar 2414.34
Mar 2414.74
Mar 2414.85
Feb 2419.27
Feb 2419.36
Feb 2419.82
Feb 2418.75
Jan 2419.92
Jan 2419.9
Jan 2420.15
Jan 2419.53
Dec 2320.01
Dec 2319.92
Dec 2319.76
Price/Operating Cashflow
0204060med 2.36Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
BIOX Price/Operating Cashflow by year
PeriodPrice/Operating Cashflow
Sep 260.47
Sep 260.46
Sep 260.47
Aug 260.45
Aug 260.48
Aug 260.49
Aug 260.37
Jul 260.39
Jul 260.37
Jul 260.38
Jul 260.37
Jul 260.36
Jun 260.36
Jun 260.41
Jun 260.46
Jun 260.46
May 260.48
May 260.45
May 260.47
May 260.36
May 260.36
Apr 260.42
Apr 260.46
Apr 260.43
Apr 260.42
Mar 260.3
Mar 260.29
Mar 260.41
Mar 260.57
Feb 260.6
Feb 260.64
Feb 260.63
Feb 260.61
Jan 260.9
Jan 261.29
Jan 261.38
Jan 261.35
Jan 261.45
Dec 251.42
Dec 251.5
Dec 251.68
Dec 251.61
Nov 251.85
Nov 251.89
Nov 252.13
Nov 252.42
Oct 252.75
Oct 252.49
Oct 252.3
Oct 251.94
Oct 251.81
Sep 252.03
Sep 252.26
Sep 252.76
Sep 253.67
Aug 253.78
Aug 253.97
Aug 253.99
Aug 254.2
Aug 254.7
Jul 255.08
Jul 254.89
Jul 255.73
Jul 256.69
Jun 256.08
Jun 256.15
Jun 2548.56
Jun 2555.99
May 2554.1
May 2551.33
May 2551.55
May 2552.22
May 2550.89
Apr 2547.67
Apr 2545.9
Apr 2548.34
Apr 2545.79
Mar 2554.32
Mar 2548.34
Mar 2551.33
Mar 2557.54
Feb 2544.57
Feb 258.9
Feb 259.7
Feb 2510.85
Jan 2513.4
Jan 2514.04
Jan 2513.47
Jan 2512.79
Jan 2512.52
Dec 2412.42
Dec 2412.1
Dec 2413.02
Dec 2412.69
Nov 2413.92
Nov 248.9
Nov 248.96
Nov 249.28
Nov 249.43
Oct 2444.1
Price to Book
00.511.5med 0.36Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
BIOX Price to Book by year
PeriodPrice to Book
Sep 260.3
Sep 260.29
Sep 260.3
Aug 260.28
Aug 260.31
Aug 260.31
Aug 260.24
Jul 260.25
Jul 260.24
Jul 260.24
Jul 260.24
Jul 260.23
Jun 260.23
Jun 260.26
Jun 260.29
Jun 260.29
May 260.31
May 260.29
May 260.3
May 260.28
May 260.28
Apr 260.32
Apr 260.35
Apr 260.33
Apr 260.32
Mar 260.23
Mar 260.22
Mar 260.31
Mar 260.12
Feb 260.13
Feb 260.14
Feb 260.13
Feb 260.13
Jan 260.19
Jan 260.27
Jan 260.29
Jan 260.29
Jan 260.31
Dec 250.3
Dec 250.32
Dec 250.36
Dec 250.34
Nov 250.39
Nov 250.32
Nov 250.36
Nov 250.33
Oct 250.37
Oct 250.33
Oct 250.31
Oct 250.26
Oct 250.24
Sep 250.27
Sep 250.3
Sep 250.37
Sep 250.49
Aug 250.51
Aug 250.53
Aug 250.54
Aug 250.56
Aug 250.63
Jul 250.68
Jul 250.66
Jul 250.77
Jul 250.9
Jun 250.82
Jun 250.83
Jun 250.79
Jun 250.92
May 250.89
May 250.84
May 250.84
May 250.85
May 250.83
Apr 250.78
Apr 250.75
Apr 250.79
Apr 250.75
Mar 250.89
Mar 250.79
Mar 250.84
Mar 250.94
Feb 250.73
Feb 250.83
Feb 250.9
Feb 251.01
Jan 251.24
Jan 251.3
Jan 251.25
Jan 251.19
Jan 251.16
Dec 241.15
Dec 241.12
Dec 241.21
Dec 241.18
Nov 241.29
Nov 241.06
Nov 241.07
Nov 241.11
Nov 241.13
Oct 241.26
Bioceres Crop Solutions Corp.
BIOX
Stockpicker

Video analysis: BIOX

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: BIOX

Bioceres Crop Solutions Reports Fiscal Fourth Quarter and Full-Year 2026 Financial and Operating Results

businesswire.com · 14 Sep 2026

Bioceres Crop Solutions Reports Fiscal Fourth Quarter and Full-Year 2026 Financial and Operating Results

ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ: BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, announced financial results for the fiscal fourth quarter ended June 30, 2026. Financial results are expressed in U.S. dollars and are presented in accordance with International Financial Reporting Standards. All comparisons in t.

Bioceres Crop Solutions to Host Fiscal Fourth Quarter and Full Year 2026 Financial Results Conference Call on Tuesday, September 15, 2026 at 8:30 a.m. Eastern Time

businesswire.com · 9 Sep 2026

Bioceres Crop Solutions to Host Fiscal Fourth Quarter and Full Year 2026 Financial Results Conference Call on Tuesday, September 15, 2026 at 8:30 a.m. Eastern Time

ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (NASDAQ: BIOX) (“Bioceres” or the “Company”), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, will hold a conference call on Tuesday, September 15, 2026 at 8:30 a.m. Eastern Time to discuss its results for the fiscal fourth quarter and full year ended June 30, 2026. A press release detailing these resul.

Pinnacle Food Group (NASDAQ:PFAI) vs. Bioceres Crop Solutions (NASDAQ:BIOX) Head to Head Contrast

defenseworld.net · 22 Jul 2026

Pinnacle Food Group (NASDAQ:PFAI) vs. Bioceres Crop Solutions (NASDAQ:BIOX) Head to Head Contrast

Pinnacle Food Group (NASDAQ: PFAI - Get Free Report) and Bioceres Crop Solutions (NASDAQ: BIOX - Get Free Report) are both small-cap consumer staples companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, institutional ownership, risk, earnings, profitability, analyst recommendations and valuation. Analyst Recommendations This is

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.